Schoen, M. W., Doherty, J. M., Touya, M., El-Chaar, N. N., Ivanova, J. I., Eaton, D. B., Zhao, D., Cohen, J., Talon, B. (2026). Outcomes with androgen-deprivation therapy (ADT) plus androgen receptor pathway inhibitors (ARPIs) in veterans with de novo metastatic castration-sensitive prostate cancer (mCSPC) who were elderly, frail, or had high comorbidity: A subgroup analysis of enzalutamide and high-volume disease.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5094